Show simple item record

dc.contributor.advisor郭朝阳
dc.contributor.author梁涛
dc.date.accessioned2017-06-20T08:13:09Z
dc.date.available2017-06-20T08:13:09Z
dc.date.issued2016-04-07
dc.identifier.urihttps://dspace.xmu.edu.cn/handle/2288/129113
dc.description.abstract人工心脏瓣膜置换手术是目前治疗瓣膜疾病最有效的方式方法。在过去的20来年发展平稳,市场竞争相对简单。但近3年来,随着经济和技术的不断发展,中国人的疾病谱也发生着巨大的变化。由风湿性病变为绝对多数向着风湿性病变,退行性病变共存的局面变化。所使用的产品也由机械瓣一家独大变为机械瓣用量逐步下降,生物瓣用量快速增长。再加上国家医保政策这几年明确要求逐步降低医用材料费用。更为重要的是替代产品介入瓣在国外已上市,随时准备进入中国市场。这些变化是中国所有人工心脏瓣膜公司共同面对的问题。如何调整竞争战略,在现状和将来的市场保持持续发展是每一个公司都需要重点考虑的问题。 该行业进入和退出的门槛都很高,对S公司...
dc.description.abstractAt present,heart valve replacement operation is the key way for heart valve disease treatment. In China, heart valve prostheses market got a 20 years sustainable growth .And the marketing competition was stable and simple.But in the past 3 years, there was milestone change .The spectrum of heart valve disease for Chinese people was changed for the economic and technology change .The degenerative p...
dc.language.isozh_CN
dc.relation.urihttps://catalog.xmu.edu.cn/opac/openlink.php?strText=51089&doctype=ALL&strSearchType=callno
dc.source.urihttps://etd.xmu.edu.cn/detail.asp?serial=54234
dc.subject人工机械瓣
dc.subject人工生物瓣
dc.subject竞争战略
dc.subjectMechanical Heart Valve
dc.subjectTissue Heart Valve
dc.subjectCompetitive Strategy
dc.titleS公司人工心脏瓣膜竞争战略研究
dc.title.alternativeCompetitive Strategy of Heart Valve Prostheses for S Ltd. Co.
dc.typethesis
dc.date.replied2015-10-28
dc.description.note学位:工商管理硕士
dc.description.note院系专业:管理学院_工商管理硕士(高级管理人员工商管理硕士)
dc.description.note学号:X2011156264


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record